Mirum Pharamceuticals (MIRM) PT Raised to $74 at Raymond James, Keeps Top Rating
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on Mirum Pharamceuticals (NASDAQ: MIRM) to $74.00 (from $70.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
